UBS Group’s Gamida Cell Ltd. Ordinary Shares GMDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-201,000
| Closed | -$7.24K | – | 10450 |
|
|
2024
Q1 | $7.24K | Buy |
+201,000
| New | +$68.7K | ﹤0.01% | 7398 |
|
|
2023
Q3 | – | Sell |
-6,057
| Closed | -$11.7K | – | 10172 |
|
|
2023
Q2 | $11.7K | Buy |
+6,057
| New | +$10.4K | ﹤0.01% | 7098 |
|
|
2023
Q1 | – | Sell |
-325
| Closed | -$419 | – | 10829 |
|
|
2022
Q4 | $419 | Buy |
+325
| New | +$514 | ﹤0.01% | 10193 |
|
|
2022
Q2 | – | Sell |
-3,882
| Closed | -$16K | – | 11224 |
|
|
2022
Q1 | $16K | Buy |
+3,882
| New | +$13K | ﹤0.01% | 7770 |
|
|
2021
Q4 | – | Sell |
-13,861
| Closed | -$54K | – | 10906 |
|
|
2021
Q3 | $54K | Sell |
13,861
-1,791
| -11% | -$8.95K | ﹤0.01% | 6283 |
|
|
2021
Q2 | $101K | Buy |
15,652
+5,087
| +48% | +$35.1K | ﹤0.01% | 5874 |
|
|
2021
Q1 | $85K | Buy |
10,565
+5,654
| +115% | +$51.9K | ﹤0.01% | 6095 |
|
|
2020
Q4 | $41K | Sell |
4,911
-12,481
| -72% | -$84.5K | ﹤0.01% | 6369 |
|
|
2020
Q3 | $73K | Buy |
17,392
+12,892
| +286% | +$54.9K | ﹤0.01% | 5387 |
|
|
2020
Q2 | $21K | Hold |
4,500
| – | – | ﹤0.01% | 6533 |
|
|
2020
Q1 | $14K | Sell |
4,500
-2,009
| -31% | -$8.51K | ﹤0.01% | 6743 |
|
|
2019
Q4 | $28K | Buy |
+6,509
| New | +$31K | ﹤0.01% | 6689 |
|
|
2019
Q2 | – | Sell |
-12,063
| Closed | -$136K | – | 8238 |
|
|
2019
Q1 | $136K | Buy |
12,063
+10,263
| +570% | +$125K | ﹤0.01% | 4860 |
|
|
2018
Q4 | $18K | Buy |
+1,800
| New | +$19.5K | ﹤0.01% | 6883 |
|
Other funds holding GMDA
UBS Group's GMDA Position: Q2 2024 in Review
UBS Group sold out of Gamida Cell Ltd. Ordinary Shares (GMDA) in Q2 2024, closing a stake of 201,000 shares — an estimated $7.24K sold.
UBS Group first reported a position in GMDA in Q4 2018 and held it in 14 quarters. The position peaked at $136K in Q1 2019. 2 funds tracked by Wall St. Rank hold GMDA as of Q2 2024.
- UBS Group reported no remaining Gamida Cell Ltd. Ordinary Shares position as of Q2 2024 after selling out during the quarter.
- UBS Group sold 201,000 Gamida Cell Ltd. Ordinary Shares shares in Q2 2024, an estimated $7.24K.
- UBS Group first reported a position in Gamida Cell Ltd. Ordinary Shares in Q4 2018 and held it in 14 quarters.
- UBS Group's Gamida Cell Ltd. Ordinary Shares position peaked at $136K in Q1 2019.
- 2 funds tracked by Wall St. Rank held Gamida Cell Ltd. Ordinary Shares as of Q2 2024.
Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.